150 related articles for article (PubMed ID: 8839934)
1. Molecular biology of mineralocorticoid metabolism.
Fardella CE; Miller WL
Annu Rev Nutr; 1996; 16():443-70. PubMed ID: 8839934
[TBL] [Abstract][Full Text] [Related]
2. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
Whorwood CB; Stewart PM
J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
[TBL] [Abstract][Full Text] [Related]
3. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Agarwal AK
Endocr Rev; 1997 Feb; 18(1):135-56. PubMed ID: 9034789
[TBL] [Abstract][Full Text] [Related]
4. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
Stewart PM; Whorwood CB; Walker BR
Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptors, salt, and hypertension.
Funder JW; Krozowski Z; Myles K; Sato A; Sheppard KE; Young M
Recent Prog Horm Res; 1997; 52():247-60; discussion 261-2. PubMed ID: 9238855
[TBL] [Abstract][Full Text] [Related]
6. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
[TBL] [Abstract][Full Text] [Related]
7. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
Mune T; Rogerson FM; Nikkilä H; Agarwal AK; White PC
Nat Genet; 1995 Aug; 10(4):394-9. PubMed ID: 7670488
[TBL] [Abstract][Full Text] [Related]
8. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
Rodríguez JA
Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
[TBL] [Abstract][Full Text] [Related]
9. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
[TBL] [Abstract][Full Text] [Related]
10. Inherited forms of mineralocorticoid hypertension.
White PC
Hypertension; 1996 Dec; 28(6):927-36. PubMed ID: 8952579
[TBL] [Abstract][Full Text] [Related]
11. Genetics of the mineralocorticoid system in primary hypertension.
Ferrari P
Curr Hypertens Rep; 2002 Feb; 4(1):18-24. PubMed ID: 11790287
[TBL] [Abstract][Full Text] [Related]
12. [11 beta-Hydroxysteroid dehydrogenase].
Sun G; Li P; Yang KP; Challis JR
Sheng Li Ke Xue Jin Zhan; 1998 Oct; 29(4):301-6. PubMed ID: 12501657
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Steroids; 1997 Jan; 62(1):83-8. PubMed ID: 9029720
[TBL] [Abstract][Full Text] [Related]
14. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
Al-Harbi T; Al-Shaikh A
J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess.
Speiser PW; Riddick LM; Martin K; New MI
Metabolism; 1993 Jul; 42(7):843-5. PubMed ID: 8393954
[TBL] [Abstract][Full Text] [Related]
16. Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues.
Sharma KK; Lindqvist A; Zhou XJ; Auchus RJ; Penning TM; Andersson S
Mol Cell Endocrinol; 2006 Mar; 248(1-2):79-86. PubMed ID: 16337083
[TBL] [Abstract][Full Text] [Related]
17. Genetic, biochemical, and clinical studies of patients with A328V or R213C mutations in 11betaHSD2 causing apparent mineralocorticoid excess.
Morineau G; Marc JM; Boudi A; Galons H; Gourmelen M; Corvol P; Pascoe L; Fiet J
Hypertension; 1999 Sep; 34(3):435-41. PubMed ID: 10489390
[TBL] [Abstract][Full Text] [Related]
18. Apparent mineralocorticoid excess: type I and type II.
Mantero F; Palermo M; Petrelli MD; Tedde R; Stewart PM; Shackleton CH
Steroids; 1996 Apr; 61(4):193-6. PubMed ID: 8732999
[TBL] [Abstract][Full Text] [Related]
19. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess.
Walker BR; Edwards CR
Endocrinol Metab Clin North Am; 1994 Jun; 23(2):359-77. PubMed ID: 8070427
[TBL] [Abstract][Full Text] [Related]
20. Disorders of mineralocorticoid synthesis.
Connell JM; Fraser R; Davies E
Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):43-60. PubMed ID: 11469810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
